Patients will be followed up every three months for a total of one year. This follow up schedule meets the current standard of care after radical prostatectomy. At each follow up a serum PSA will be assessed for recurrence on prostate cancer. To investigate primary and secondary endpoints a self-reported validated questionnaire will be provided assessing measures of potency. Finally, the use of pads for urinary leakage will be assessed at each time point.